Expert Brief 2: Cardiovascular Considerations for the Person with Type 2 Diabetes

CAN-eng

$0

free

CCCEP

< 30 min

Endocrinology

0.25 Credits

This course is expired! Browse All Courses
LEARN MORE

Course Description

This video helps pharmacists understand the importance of cardiorenal protection in people with Type 2 Diabetes. The goal is to review the current evidence on cardiovascular outcomes and to help pharmacists apply current guideline recommendations to support the management of people with type 2 diabetes with particular cardiovascular considerations.

This program has received an unrestricted educational grant or in-kind support from Abbott, Janssen and Novo Nordisk.

Course Details

Expiry Date: 2022-10-22

Professions: Pharmacy

Faculty

Michael Boivin, B.SC. Pharm, CDE, CTH

Rick Siemens, B.Sc. Pharm., B.Sc. Biol., CDE, CPT

Susie Jin, RPh, CDE, CRE

Akshay Jain, MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

James Kim, MBBCh, PgDip

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.25 CEUs.
CCCEP File Number: 1066-2021-3286-I-P

This program is developed in collaboration with Partners in Progressive Medical Education (PPME).

Learning Objective(s)

Upon completion of this continuing education program, participants will be better able to:

  • Recognize cardiorenal risk factors and the benefit of cardiorenal protection in people
    with type 2 diabetes
  • Discuss the evidence on cardiorenal outcomes of antihyperglycemic agents, including the reduction of major adverse cardiac events (MACE) and hospitalization for heart failure (HHF)
  • Identify pharmacologic agent(s) with demonstrated cardiorenal benefits that would be recommended for specific individuals with type 2 diabetes
This course is expired! Browse All Courses